Ingevity Corp buy BMO Capital Markets
Start price
07.08.25
/
50%
€40.88
Target price
07.08.26
€53.17
Performance (%)
20.40%
Price
19.12.25
€50.25
Summary
This prediction is currently active. The prediction currently has a performance of 20.40%. This prediction currently runs until 07.08.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -1.760% | -1.760% |
| iShares Core DAX® | 0.299% | 4.394% |
| iShares Nasdaq 100 | 0.666% | 1.175% |
| iShares Nikkei 225® | -0.656% | -0.055% |
| iShares S&P 500 | 0.352% | 1.378% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity Corporation (NYSE: NGVT) had its price target raised by analysts at BMO Capital Markets from $56.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat